Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cardiovascular Research

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvq308PMID 20880837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING

  2013cited by this paper
• Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.

  2010cited by this paper
• Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload.

  2010cited by this paper
• CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model.

  2010cited by this paper
• Regulation of Cardiac Gene Expression by KLF15, a Repressor of Myocardin Activity*

  2010cited by this paper
• Myocardin-Related Transcription Factor-A Controls Myofibroblast Activation and Fibrosis in Response to Myocardial Infarction

  2010influential reference
• New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies.

  2010influential reference
• MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

  2009cited by this paper
• Origin of Cardiac Fibroblasts and the Role of Periostin

  2009cited by this paper
• Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy.

  2009cited by this paper
• Connective tissue growth factor and cardiac fibrosis

  2009cited by this paper
• Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.

  2009cited by this paper
• Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload

  2009cited by this paper
• Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences

  2008cited by this paper
• LNA-mediated microRNA silencing in non-human primates

  2008cited by this paper
• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

  2008influential reference
• Periostin as a Heterofunctional Regulator of Cardiac Development and Disease

  2008cited by this paper
• Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.

  2008influential reference
• microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.

  2008cited by this paper
• Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

  2008cited by this paper
• Serotonin and Angiotensin Receptors in Cardiac Fibroblasts Coregulate Adrenergic-Dependent Cardiac Hypertrophy

  2008cited by this paper
• Expression of Connective Tissue Growth Factor in the Human Liver with Idiopathic Portal Hypertension

  2007cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway.

  2007cited by this paper
• Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway

  2007cited by this paper
• Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

  2007cited by this paper
• Increased Connective Tissue Growth Factor Relative to Brain Natriuretic Peptide as a Determinant of Myocardial Fibrosis

  2007cited by this paper
• Abstract 1219: The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts.

  2006cited by this paper
• A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

  2006cited by this paper
• Alterations in cultured myocardial fibroblast function following the development of left ventricular failure.

  2006cited by this paper
• Altered fibroblast function following myocardial infarction.

  2005cited by this paper
• N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma.

  2005cited by this paper
• TGF-β1 and angiotensin networking in cardiac remodeling

  2004cited by this paper
• TGF‐β signaling and the fibrotic response

  2004cited by this paper
• Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

  2004cited by this paper
• TGF-beta1 and angiotensin networking in cardiac remodeling.

  2004cited by this paper
• Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27

  2004cited by this paper
• Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes.

  2004cited by this paper
• Effect of Donor/Recipient Body Weight Mismatch on Patient and Graft Outcome in Living-Donor Kidney Transplantation

  2003cited by this paper
• Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development

  2003cited by this paper
• Biological activities of fibroblast growth factor-2 in the adult myocardium.

  2003cited by this paper
• Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy

  2002cited by this paper
• Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).

  2002cited by this paper
• Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1

  2002cited by this paper
• Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension

  2002cited by this paper
• Transforming Growth Factor-β Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats

  2002cited by this paper
• TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II

  2002cited by this paper
• Mutation in collagen gene induces cardiomyopathy in transgenic mice *

  2002cited by this paper
• TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

  2002cited by this paper
• Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.

  2002cited by this paper
• Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.

  2001cited by this paper
• Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease.

  2001cited by this paper
• Sp1 and Smad Proteins Cooperate to Mediate Transforming Growth Factor-β1-induced α2(I) Collagen Expression in Human Glomerular Mesangial Cells*

  2001cited by this paper
• Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship

  2001cited by this paper
• Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice

  2000cited by this paper
• Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice.

  2000cited by this paper
• CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.

  2000cited by this paper
• TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice

  2000cited by this paper
• Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese.

  2000cited by this paper
• Myocardial Mechanics and Collagen Structure in the Osteogenesis Imperfecta Murine (oim)

  2000cited by this paper
• Matrix gene expression and decompensated heart failure: the aged SHR model.

  2000cited by this paper
• Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES)

  2000cited by this paper
• Distinct Oligomeric States of SMAD Proteins in the Transforming Growth Factor-β Pathway*

  2000cited by this paper
• Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart.

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling*

  1999cited by this paper
• Smads bind directly to the Jun family of AP-1 transcription factors.

  1999cited by this paper
• Regulation of cardiovascular collagen synthesis by mechanical load.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP

  1999cited by this paper
• Connective tissue growth factor mediates transforming growth factor b-induced collagen synthesis : down-regulation by cAMP

  1999cited by this paper
• Molecular mechanisms of myocardial remodeling.

  1999cited by this paper
• Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats.

  1998cited by this paper
• Differential protein expression and subcellular distribution of TGFbeta1, beta2 and beta3 in cardiomyocytes during pressure overload-induced hypertrophy.

  1997influential reference
• Differential Protein Expression and Subcellular Distribution of TGFβ1,β2andβ3in Cardiomyocytes During Pressure Overload-induced Hypertrophy

  1997cited by this paper
• Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.

  1997cited by this paper
• Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells.

  1996cited by this paper
• Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function.

  1995cited by this paper
• The TGFβ superfamily in myocardium: Ligands, receptors, transduction, and function

  1995cited by this paper
• Progression of heart failure: A role for interstitial fibrosis

  1995cited by this paper
• The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function.

  1995cited by this paper
• Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts.

  1994cited by this paper
• Normal left ventricular diastolic compliance after regression of hypertrophy.

  1994cited by this paper
• Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

  1994cited by this paper
• Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

  1993cited by this paper
• Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric study.

  1993cited by this paper
• Collagen expression in mechanically stimulated cardiac fibroblasts.

  1991cited by this paper
• Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations.

  1990cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis.

  1990cited by this paper
• Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle.

  1988cited by this paper
• Collagen Remodeling of the Pressure‐Overloaded, Hypertrophied Nonhuman Primate Myocardium

  1988cited by this paper
• Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix.

  1987cited by this paper
• Connective tissue content and myocardial stiffness in pressure overload hypertrophy A combined study of morphologic, morphometric, biochemical, and mechanical parameters

  1983cited by this paper
• The effect of lathyrogen beta-amino proprionitrile (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle.

  1978cited by this paper
• Treatment of Congestive Heart Failure Interfering the Aldosterone-cardiac Extracellular Matrix Relationship

  year unknowncited by this paper

• Obesity-Associated Cardiac Fibrosis: Mechanisms and Emerging Therapeutic Targets

  2026cites this paper
• Implication of intracellular chloride channel in extracellular matrix remodeling in pressure‐overloaded mice and patients with dilated cardiomyopathy

  2026cites this paper
• Aortic Stenosis as a Mechanical Stressor and Tissue Energetics: Consistent Clue with Hypertensive Stress Septal Sign

  2026cites this paper
• Stable and functional regulatory T cell attenuates fibrotic remodeling in heart failure.

  2026cites this paper
• LncRNA NAV2-AS2 is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis.

  2025cites this paper
• A computational model of age-dependent cardiomyocyte apoptosis.

  2025cites this paper
• PGRMC2 is a pressure-volume regulator critical for myocardial responses to stress in mice

  2025cites this paper
• FGF21-FGFR1 signaling protects against cardiac hypertrophy by regulating PINK1-mediated mitophagy pathway.

  2025cites this paper
• Identification of novel therapeutic targets for atrial fibrillation through Mendelian randomization analysis of druggable genes.

  2025cites this paper
• Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models

  2025cites this paper
• Calpain inhibition as a novel therapeutic strategy for aortic dissection with acute lower extremity ischemia

  2025cites this paper
• Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy

  2025cites this paper
• TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6

  2024cites this paper
• Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).

  2024cites this paper
• Notum protects against myocardial infarction-induced heart dysfunction by alleviating cardiac fibrosis

  2024cites this paper
• Melanoma differentiation-associated protein 5 prevents cardiac hypertrophy via apoptosis signal-regulating kinase 1-c-Jun N-terminal kinase/p38 signaling.

  2024cites this paper
• Current experimental and early investigational agents for cardiac fibrosis: where are we at?

  2024cites this paper
• Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes

  2024cites this paper
• Epicardium and Coronary Vessels.

  2024cites this paper
• Assessment of ursolic acid effect on in vitro model of cardiac fibrosis.

  2024cites this paper
• Molecular Pathways and Animal Models of Cardiomyopathies.

  2024cites this paper
• Permanent Pacemaker Implantation: Early Post-Implantation Data

  2024cites this paper
• Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype

  2023cites this paper
• Myocardial Remodeling in Early Chronic Kidney Disease—Mineral and Bone Disorder Model with Low Bone Turnover

  2023cites this paper
• Advances in the design, generation, and application of tissue-engineered myocardial equivalents

  2023cites this paper
• Relationship between CTGF levels and echocardiographic parameters in patients after permanent pacemaker implantation

  2023cites this paper
• The role of complement C3 in the outcome of regional myocardial infarction

  2023cites this paper
• TXNIP aggravates cardiac fibrosis and dysfunction after myocardial infarction in mice by enhancing the TGFB1/Smad3 pathway and promoting NLRP3 inflammasome activation

  2023influential citation
• MicroRNA‑378: An important player in cardiovascular diseases (Review)

  2023cites this paper
• Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling

  2023cites this paper
• Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium

  2023cites this paper
• Acacetin Alleviates Cardiac Fibrosis via TGF-β1/Smad and AKT/mTOR Signal Pathways in Spontaneous Hypertensive Rats

  2023cites this paper
• Inhibition of miR-543 alleviates cardiac fibroblast-to-myofibroblast transformation and collagen expression in insulin resistance via targeting PTEN.

  2023cites this paper
• Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy.

  2022cites this paper
• Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice

  2022cites this paper
• Culturing of Cardiac Fibroblasts in Engineered Heart Matrix Reduces Myofibroblast Differentiation but Maintains Their Response to Cyclic Stretch and Transforming Growth Factor β1

  2022cites this paper
• Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway

  2022cites this paper
• THE IMMOBILIZING INTERSTITIAL FIBROSIS OF THE HEART

  2022cites this paper
• Inhibition of TRIF-Dependent Inflammation Decelerates Afterload-Induced Myocardial Remodeling

  2022cites this paper
• State of Change: Epigenetic and Mitochondrial Regulation of Cardiac Fibroblast Activation

  2022cites this paper
• Ex Vivo Hydrostatic Pressure Loading of Atrial Tissues Activates Profibrotic Transcription via TGF-β Signal Pathway.

  2022cites this paper
• MiRNA-Mediated Fibrosis in the Out-of-Target Heart following Partial-Body Irradiation

  2022cites this paper
• Loss of talin in cardiac fibroblasts results in augmented ventricular cardiomyocyte hypertrophy in response to pressure overload.

  2022cites this paper
• Integrins in cardiac fibrosis.

  2022cites this paper
• ChGn‐2 Plays a Cardioprotective Role in Heart Failure Caused by Acute Pressure Overload

  2022cites this paper
• Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond

  2022cites this paper
• Loureirin B alleviates cardiac fibrosis by suppressing Pin1/TGF-β1 signaling.

  2022cites this paper
• Cardiac Remodeling in Hypertension: Clinical Impact on Brain, Heart, and Kidney Function.

  2022cites this paper
• High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction

  2022cites this paper
• Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice

  2022cites this paper
• Cardiac Microvascular Endothelial Cells in Pressure Overload-Induced Heart Disease.

  2021cites this paper
• Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review

  2021cites this paper
• Heart failure with preserved ejection fraction based on aging and comorbidities

  2021cites this paper
• Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun signaling.

  2021cites this paper
• Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.

  2021cites this paper
• Biomarkers ST2 and interleukin 33 for assessing the severity of cardiac inflammation and fibrosis in patients with chronic heart failure

  2021cites this paper
• Notum Protects Against Myocardial Infarction-Induced Heart Dysfunction By Alleviating Cardiac Fibrosis

  2021cites this paper
• Postsystolic thickening is a potential new clinical sign of injured myocardium in marfan syndrome

  2021cites this paper
• Speckle Tracking Echocardiography Verified the Efficacy of Qianyangyuyin Granules in Alleviating Left Ventricular Remodeling in a Hypertensive Rat Model

  2021cites this paper
• Inhibition of the canonical Wnt signaling pathway by a β-catenin/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis

  2021cites this paper
• Resistin deletion protects against heart failure injury by targeting DNA damage response.

  2021cites this paper
• Stimulation of Sigma-1 Receptor Protects against Cardiac Fibrosis by Alleviating IRE1 Pathway and Autophagy Impairment

  2021cites this paper
• Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload

  2021cites this paper
• Targeting fibrosis in the failing heart with nanoparticles.

  2021cites this paper
• Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics

  2021cites this paper
• A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis

  2021cites this paper
• FGF23 and heart and vascular disease

  2021cites this paper
• Cardiac hybrid imaging: novel tracers for novel targets

  2021cites this paper
• Volumetric histogram-based analysis of cardiac magnetic resonance T1 mapping: A tool to evaluate myocardial diffuse fibrosis.

  2021cites this paper
• Cardiac pathophysiology in sickle cell disease

  2021cites this paper
• Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis

  2021influential citation
• Epidemiology and pathogenesis of heart failure with preserved ejection fraction.

  2020cites this paper
• Current understanding of fibrosis in genetic cardiomyopathies.

  2020cites this paper
• Cardiac fibrosis: emerging agents in preclinical and clinical development

  2020cites this paper
• Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy.

  2020cites this paper
• Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure

  2020cites this paper
• Galectin-3 knock down inhibits cardiac ischemia-reperfusion injury through interacting with bcl-2 and modulating cell apoptosis.

  2020cites this paper
• Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy

  2020cites this paper
• Protective Effect of Vitis labrusca Leaves Extract on Cardiovascular Dysfunction through HMGB1-TLR4-NFκB Signaling in Spontaneously Hypertensive Rats

  2020cites this paper
• The Cell Type–Specific Functions of miR-21 in Cardiovascular Diseases

  2020cites this paper
• Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia

  2020cites this paper
• Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure

  2020cites this paper
• Interventionelle Therapie von AV-Klappenerkrankungen – Kriterien für die Zertifizierung von Mitralklappenzentren

  2020cites this paper
• Luhong Formula Has a Cardioprotective Effect on Left Ventricular Remodeling in Pressure-Overloaded Rats

  2020cites this paper
• A Peptide-Functionalized Magnetic Nanoplatform-Loaded Melatonin for Targeted Amelioration of Fibrosis in Pressure Overload-Induced Cardiac Hypertrophy

  2020cites this paper
• Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future

  2020cites this paper
• Computational modeling of cardiac growth and remodeling in pressure overloaded hearts—Linking microstructure to organ phenotype

  2020cites this paper
• Anesthetic-induced myocardial conditioning: molecular fundamentals and scope.

  2020cites this paper
• Cardiac Fibrosis and Cardiac Fibroblast Lineage-Tracing: Recent Advances

  2020cites this paper
• CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts

  2020cites this paper
• H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts

  2020cites this paper
• Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate.

  2020cites this paper
• Characterization of a novel interaction between four-and-a-half-LIM domains 2 and cardiomyopathy-associated protein 5 in cardiac myocytes

  2020cites this paper
• Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway

  2020cites this paper
• Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure

  2020cites this paper
• Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure

  2020cites this paper
• Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload

  2020cites this paper
• Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

  2019cites this paper
• Therapeutic progress and knowledge basis about natriuretic peptide system in heart failure.

  2019cites this paper
• Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome

  2019cites this paper